Danaher Corporation
NYSE:DHRMedical - Diagnostics & Research
-$0.38 today
- Market cap
- $160.69B
- Beta
- 0.83
- P/E (TTM)
- 34.0
- EPS (TTM)
- $5.21
- Dividend yield
- 0.77%
Volume 2.92M
Average 4.52M
DHR Total Non-current Liabilities
All obligations due after more than one year.
Danaher CorporationNYSE: DHR
Total Non-current Liabilities · Q3 FY2026 · quarter ended Sep 2026
Total non-current liabilities rises 36.0% from a year ago
Total non-current liabilities stood at $30.61B at the end of Q3 FY2026, up 36.0% from a year earlier and down 3.4% from the prior quarter. Over 3 fiscal years it compounded at -2.3% a year.
Context
- Total non-current liabilities amounted to 32.8% of total assets at the end of Q3 FY2026, up 4.7 pp from a year earlier.
- Total non-current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +36.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 24.12B USD
- Year-over-year change
- +13.8%
- 4-year CAGR
- -5.2%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 24.12B | +13.8% |
| FY2024 | 2024-12-31 | 21.19B | -6.7% |
| FY2023 | 2023-12-31 | 22.72B | -12.2% |
| FY2022 | 2022-12-31 | 25.87B | -13.4% |
| FY2021 | 2021-12-31 | 29.87B | — |
Total Non-current Liabilities vs competitors
How DHR compares with its peers on the latest reported figures
- DHR's Sep 2026 total non-current liabilities of $30.61B is the 2nd highest of the 9 companies compared; the peer median is $3B.
- Its year-over-year change of +36.0% is the 3rd highest of 9, against a peer median of +2.6%.
- Total non-current liabilities amounts to 32.8% of total assets for DHR, versus a peer median of 33.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $45.3B | +22.5% | +5.0% | 39.7% | |
| Sep 2026 | $30.61B | +36.0% | -2.3% | 32.8% | |
| Jul 2026 | $7.16B | +364.1% | -13.8% | 28.9% | |
| Jul 2026 | $4.32B | +8.9% | +2.6% | 30.9% | |
| Jul 2026 | $3.54B | -14.4% | -11.7% | 29.4% | |
| Jun 2026 | $2.46B | -3.7% | +3.0% | 66.9% | |
| Jun 2026 | $2.39B | -23.4% | +16.1% | 39.5% | |
| Jun 2026 | $2.23B | -5.7% | -6.7% | 33.6% | |
| Jun 2026 | $1.95B | +63.9% | +2.8% | 33.1% | |
| Peer median (excluding DHR) | $3B | +2.6% | +2.7% | 33.4% | |
Competitors are the stored peer set for DHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.59B | 6B | 5.86B | 2.08B | 4.62B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.44B | 5.06B | 4.64B | 4.39B | 3.91B |
| Inventory | 2.77B | 2.77B | 2.59B | 2.33B | 2.49B |
| Other Current Assets | 82M | 1.36B | 71M | 79M | 1.74B |
| Total Current Assets | 11.65B | 15.88B | 13.94B | 9.5B | 12.76B |
| Property, Plant & Equipment (Net) | 4.83B | 4.59B | 5.61B | 6.07B | 6.75B |
| Goodwill | 41.18B | 37.28B | 41.61B | 40.5B | 43.15B |
| Intangible Assets | 22.84B | 19.82B | 20.75B | 18.57B | 17.82B |
| Long-term Investments | 1.32B | 2.16B | 1.7B | 1.82B | 1.55B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.36B | 4.61B | 896M | 1.09B | 1.45B |
| Total Non-current Assets | 71.54B | 68.47B | 70.55B | 68.05B | 70.71B |
| Total Assets | 83.18B | 84.35B | 84.49B | 77.54B | 83.46B |
| Account Payables | 2.57B | 1.86B | 1.77B | 1.75B | 1.84B |
| Short-term Debt | 215M | 758M | 1.88B | 505M | 2M |
| Tax Payables | 707M | 691M | 582M | 0 | 0 |
| Deferred Revenue | 1.61B | 1.46B | 1.47B | 1.3B | 0 |
| Other Current Liabilities | 1.59B | 2.48B | 1.4B | 1.34B | 4.96B |
| Total Current Liabilities | 8.14B | 8.39B | 8.27B | 6.8B | 6.81B |
| Long-term Debt | 22.17B | 19.09B | 16.71B | 15.5B | 18.42B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 213M | 221M | 249M | 232M | 0 |
| Other Non-current Liabilities | 6.6B | 5.79B | 4.81B | 4.49B | 5.71B |
| Total Non-current Liabilities | 29.87B | 25.87B | 22.72B | 21.19B | 24.12B |
| Total Liabilities | 38.01B | 34.26B | 31B | 27.99B | 30.93B |
| Common Stock | 9M | 9M | 9M | 9M | 9M |
| Retained Earnings | 32.83B | 39.21B | 41.07B | 44.19B | 46.89B |
| Accumulated OCI | (1.03B) | (2.87B) | (1.75B) | (3.22B) | (207M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 10M | 8M | 4M | 7M | 7M |
| Total Equity | 45.18B | 50.09B | 53.49B | 49.55B | 52.54B |
| Total Debt | 23.27B | 20.62B | 19.54B | 17.15B | 18.42B |
| Net Debt | 20.69B | 14.62B | 13.67B | 15.07B | 13.8B |
Danaher Corporation
NYSE:DHR
Intrinsic Alpha fair value
Locked
Current Price
$228.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.